WHO recommends antibody treatment for high-risk COVID-19 patients
eMediNexus, 24 September 2021
remove_red_eye 522 Views
#Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Coronavirus Live Count Map India
remove_red_eye 522 Views
COVID-19 Vaccine Updates
Coronavirus Protocols
#Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
The World Health Organization (WHO) has recommended the use of Regeneron synthetic antibody treatment for COVID-19 in patients with some specific health profiles.Individuals who have non-severe COVID-19 and are still at high risk of hospitalization can be given the antibody combination. It can also be administered to severely ill patients who are not able to mount an adequate immune response. The findings are published in the BMJ.Regeneron is a combination of synthetic antibodies casirivimab and...
Create Account
Login Now
To read the complete article ,
create a free account.
Sign Up
to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
